Posts Tagged ‘Schedule II’

2018 Arizona Opioid Epidemic Act: Pharmacist and Pharmacy Rule Changes

Earlier this year, Arizona passed the Arizona Opioid Epidemic Act (Act), a comprehensive, bipartisan bill aimed at combating the opioid epidemic. The new legislation addresses opioid treatment, opioid enforcement and oversight, opioid addiction and reversing opioid overdoses. Pharmacists and pharmacies must be aware of a few important rule changes slated to start April 26, 2018,…

Read More

Pharmacists Must Ensure Prescription Orders are Issued for a Legitimate Medical Purpose by an Authorized Prescriber and Have a Recognized Medical Utility or Application

As discussed previously on the Baer Law Blog, corresponding responsibility remains one of the most misunderstood or unknown concepts found in the Drug Enforcement Administration’s (DEA) regulations. The DEA’s regulations (21 CFR 1306.04) regarding corresponding responsibility state: A prescription for a controlled substance to be effective must be issued for a legitimate medical purpose by an…

Read More

Hydrocodone Combination Products Moving to Schedule II

On August 22, the Drug Enforcement Agency (DEA) published a final rule to move hydrocodone combination products (HCPs) from Schedule III to Schedule II. The change takes effect on October 6, 2014. Under the finale rule, all Schedule II requirements with respect to security, labeling and packaging, inventory, record keeping and reporting, etc., will apply to…

Read More